LIGAND PHARMACEUTICALS INC
LGND
30 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Sep 20 9:39 PM | Espinoza Octavio | Proposed Sale | 1,275 | $103.94 | $132.5K | — | View → |
| Aug 28, 2024 | Aug 28 8:39 PM | Reardon Andrew | Proposed Sale | 1,500 | $106.39 | $159.6K | — | View → |
| Aug 22, 2024 | Aug 22 10:05 PM | Korenberg Matthew E | Proposed Sale | 18,858 | $105.03 | $2.0M | — | View → |
| Nov 11, 2024 | — | Korenberg Matthew E | Proposed Sale | 32,183 | $120.33 | $3.9M | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Jun 18 12:37 PM | Stephen L SabbaDirector | Option Exercise | 2,145 | $66.13 | 0(D) | View → |
| Jun 12, 2026 | Jun 16 1:06 AM | Jason HaasDirector | Option Exercise | 4,000 | $51.56 | 6,138(D) | View → |
| Jun 5, 2026 | Jun 12 9:27 PM | Jason AryehDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:42 PM | Martine ZimmermannDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:41 PM | Stephen L SabbaDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:41 PM | John L LamattinaDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:40 PM | John W KozarichDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:35 PM | Jason HaasDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:35 PM | Nancy Ryan GrayDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 1, 2026 | Jun 2 10:22 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 39,444(D) | View → |
| May 27, 2026 | May 28 11:43 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 1,736 | $63.62 | 17,407(D) | View → |
| May 13, 2026 | May 15 1:08 AM | John W KozarichDirector | Option Exercise | 1,575 | $69.51 | 0(D) | View → |
| May 12, 2026 | May 15 1:08 AM | John W KozarichDirector | Option Exercise | 459 | $69.51 | 1,575(D) | View → |
| May 1, 2026 | May 5 12:20 AM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 44,444(D) | View → |
| Apr 1, 2026 | Apr 2 10:56 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 49,444(D) | View → |
| Mar 6, 2026 | Mar 31 9:53 PM | John L LamattinaDirector | Option Exercise | 2,161 | $114.15 | 0(D) | View → |
| Mar 2, 2026 | Mar 28 1:20 AM | Octavio EspinozaChief Financial Officer | Grant/Award | 23,527 | $202.55 | 23,527(D) | View → |
| Mar 2, 2026 | Mar 28 12:33 AM | Todd C DavisDirector, Chief Executive Officer | Grant/Award | 50,058 | $202.55 | 50,058(D) | View → |
| Mar 2, 2026 | Mar 28 12:16 AM | Andrew ReardonCLO & Secretary | Grant/Award | 21,525 | $202.55 | 21,525(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
Page 1 of 2
Next →